EDITORIAL
Review and analysis of scientific sources available, were done for the subject of polymorbidity concept, which revealed nonsufficient specifics of comorbidity and polymorbidity definitions and as a result — confusion in the usage of the terms. Most authors agree that the core of polymorbidity is presence of more than one disease in one patient. Such comorbid diseases can be pathogenetically related and not correlated. Regardless of this, the grade of polymorbidity always influences prognosis and life quality.
ORIGINAL ARTICLE
Aim. To study clinical and anamnestic specifics, management and outcomes of acute myocardial infarction (MI) in patients with atypical clinical presentation.
Material and methods. Among the Tomsk population, those having had acute MI in 2009-2014 y. were included, registered in the database “Registry of Acute MI” (n=5602), and selected to groups with atypical (n=1319) and common (n=4283) clinical presentation of the MI onset. Statistics was done with software “Statistica 10”.
Results. Atypical presentation of MI took place in 23,5% cases. These patients were much older than those with common angina at MI onset; they had more prevalent arterial hypertension, obesity, diabetes. Also, the prevalence of anamnestic MI did not differ between groups, however autopsy revealed more common painless MI. Atypical MI presentation patients sought for medical care in 28 days before the event of MI more frequently than those with typical clinical picture: 36% vs. 26% (p<0,001), but electrocardiography was ordered only for a half of them (54%), that led to misdiagnostics of pre-infarction condition. Every second patient with atypical MI was hospitalized to non-specialized unit, where could not receive high-technology treatment, which hence led to worse outcomes and prognosis.
Conclusion. It is necessary to be careful with non-typical MI development possibility in older patients with several comorbidities, and with anamnesis of painless acute MI. Chance of fatal outcome in atypical MI is 10 times higher in this group than in those with typical clinical presentation.
Aim. To evaluate medical and social status, life quality, prevalence of modifiable risk factors (RF) of atherosclerosis in patients after acute myocardial infarction (MI), and to evaluate the risk of cardiovascular diseases in this category of patients.
Material and methods. Totally, 200 patients with MI diagnosis were questioned. Age 32-65 y.o. (mean age 50,4±1,4). Responders were Chelyabinsk and suburbs inhabitants. Responders were invited to reply on social status, life quality before MI, prevalence of modifiable RF of atherosclerosis.
Results. Average evaluation of social wellbeing and life quality before MI was at a satisfactory level. An exclusion was income by 1 family member (below average). Prevalence of RF of atherosclerosis: chronic stress — 72,0%, arterial hypertension — 67,5%, overweight — 55,0%, smoking — 49,0%, high cholesterol — 42,5%, hypodynamia — 20,5%, hyperglycemia — 18,5%, non-rational food habits — 16,5%. Only 26,0% of responders linked the development of MI with their lifestyle. Conclusion. At an example of MI patients, predominantly of economically active age, living in large industrial city, the risks for cardiovascular pathology were estimated: low family income (53,5%), insufficient information on negative influences of modifiable RF of atherosclerosis and their high prevalence.
CHRONIC HEART FAILURE
Aim. To study the influence of polymorphism of the gene methyltetrahydrofolate-reductase (MTHFR) — polymorhic locus С677Т, and level of homocysteine in blood plasma on the risk of development and course of chronic heart failure (CHF).
Material and methods. Totally, 277 persons studied with CHF II-IV functional classes (FC NYHA). The polymorphism С677Т of gene MTHFR studied via polymerase chain reaction. With the aim to reveal association of homocysteine with the course of CHF patients were selected by the results of year-long observation to 2 groups: with benign (n=49) and adverse (n=45) course. During the period the following was assessed: increase of symptoms and severity of CHF, hospitalizations rate, dynamics of the left ventricle ejection fraction.
Results. Carriage of allele T and genotype T/T of polymorphic locus С677Т gene MTHFR was associated with more severe clinical picture of CHF. In CHF patients of II-IV FC homocysteine concentration in serum was significantly, 2-3 times, higher comparing to the controls, regardless of age. In adverse course group the level was highest comparing to benign course.
Conclusion. The relation revealed of hyperhomocysteinemia with severity and character of CHF course. Assessment of homocysteine level in serum, and genetic polymorphism С677Т of gene MTHFR can be recommended for earlier prediction of severity of CHF.EPIDEMIOLOGY AND PREVENTION
Aim. To assess rate of familiarity and specifics of treatment with statins among the citizens of economically active age with various cardiovascular risk by the data from epidemiological study ESSE-RF (Epidemiology of Cardiovascular Diseases in Different Russian Federation Regions). Material and methods. In the work the data from ESSE-RF study was used, of representative selection of non-organized male and female inhabitants aged 25-64 y.o. from 13 regions, investigated during 2012-2014. Responded ~80%. The study included questionning by standard scale that included data on the anamnesis, etc. Lipid profile, including total cholesterol (TC), cholesterol of lipoproteids low and high density were measured at SSRCPM and RSPCC.
Results. Analysis of the whole selection showed that 20% of men and 32% of women knew their TC, and 13,6% and 18,2% were even familiar having increased level of TC. Part of those with high and very high risk was 31,3%, incl. men — 42,2%, women — 30,9%. Statins took ~7,0% of patients from this risk category. Effectiveness of treatment (target levels reached of low density cholesterol) in these groups of men and women was 14,4% and 4,8%, respectively.
Conclusion. The data obtained in populational study points on insufficient knowledge and low rate of statin treatment of the persons with high and very high cardiovascular risk in RF, which confirms the anxiety provoking data of registries and other studies. The data dictates necessity of development and implementation of specific educational programs for citizens, of physician improvement and availability of cheap but effective lipid-lowering medications.
Aim. To evaluate prevalence of the main risk factors (RF) and fatal outcome probability of cardiovascular diseases (CVD) in 10 years among men 42-44 years old.
Material and methods. Totally, 303 men studied at the age 42-44 y.o., under the ordinary step of 32-year lasting prospective cohort study. Response on invitation for investigation was 30,1%. Subjects underwent standardized questionnaire; triple blood pressure measurement, as pulse, length and mass of body; thickness of adipose layers over triceps, scapula and abdominal wall measurement; waist and hip circumference; measurement of total and high density lipoproteides cholesterol, as triglycerides and blood glucose. Statistics was done via software IBM SPSS Statistics 22.
Results. The characteristics of the studied group is presented as simple descriptive statistics. At the moment of study, 23% of men had elevated blood pressure, mostly at the level of arterial hypertension (AH) grade 1 (14,5%). There was anamnesis of AH in 44,6% participants and 27,1% take antihypertensive medication, but just 8,9% do treat actively. Overweight and obesity were found in 67% of the studied. Abdominal obesity was found in 87 (28,7%). More than 40% of them smoke. In 42,6% of men there were significant proatherogenic changes in serum found.
Low physical activity was set for 26,1% of the studied. 65% of men from this group have 2 and more risk factors. It is stated that most of the men (90%) have moderate risk of fatal CVD development next 10 years, by SCORE, and just 8,9% have low estimated risk. The main impact on the overall risk have cholesterol (47,6%) and smoking (33,7%).
Conclusion. High rate of the main RF for CVD in men 42-44 y.o. and moderate probability of fatal CVD for the next 10 years strictly dictate on the necessity of individualized active prevention of CVD with the main direction towards positive motivation for healthy life style — cessation of bad habits, especially smoking, rational food intake, physical activity optimization, atherogenic lipid profile correction and effective AH treatment.
Aim. To assess the opportunities for registry methodology for comparative evaluation of clinical and anamnestic characteristics of cardiological patients with and without obesity; to draw a “portrait” of the obese patients, common for the cohort studied.
Material and methods. The data analyzed from outpatient PROFILE registry during January 2011 to 31 august 2015: totally 1531 primary patient included, of those body mass index (BMI) collected in 1371. In 565 there was obesity of various grade, in 806 BMI was not higher than 30 kg/m2. The analysis done of retrospective data.
Results. According to PROFILE results, obesity was found in 41,2% of patients, and those with obesity were younger (p=0,003). Among them men and women number was equa — 50,8% and 49,2%, resp. For the obese there were characteristic presence of dyspnea, oedema and low level of physical activity (p=0,0001). The obese had 1,5-3 times more common arterial hypertension, 2 type diabetes, chronic heart failure (p=0,0001), glucose tolerance disordered (p=0,001), dyslipidemia (p=0,012). Regardless that the obese took medications more commonly (p=0,006), they more rarely reached target level of blood pressure (BP), than those non obese (p<0,05). Almost nobody of those with obesity had prescribed therapy against overweight, except 73 patients that participated in 2 clinical trials.
Conclusion. The data from outpatient registry PROFILE has confirmed the main information on obesity in cardiological patients: a “portrait” is drawn of the obese, cardiovascular risk factors (CRF) formulated, and comorbidities. The data demonstrates more difficult achievement of target BP in the obese with regular medication treatment, and highlights insufficient attention of physicians to diagnostics and especially treatment of obesity, as underestimation of the overweight problem by patients themselves.
Aim. To assess the specifics of unhealthy diet (UD) as risk factor (RF) of cardiovascular diseases (CVD) in rural population of Krasnodarski Krai. Material and methods. Population sample over 18 y. old was assessed, living in rural areas of Krasnodarski Krai. Totally, 2189 persons included (54,0% women, 46,0% men), mean age 47,72±16,6 y. UD was assessed by questionnaires, i.e. by unified questionnaire included to the main screening score, by the following criteria: excessive salt consumption (ESC), excessive sugars consumption (ESuC), nonsufficient vegetables and fruits consumption (NVFC), absence of control over fat amounts consumed (ACOFC). Also blood pressure was measured (BP), waist and hips circumference, body mass index (BMI), total cholesterol, glucose. Results. Prevalence of UD was 50,8% in Krasnodarski Krai, incl. ACOFC — 50,1%, ESC — 41,0%, ESuC — 39,2%, NVFC — 35,2%. Among men more common were NVFC, ESC, ACOFC, among women — ESuC (р<0,0001). Prevalence of UD increased with age (р<0,0001) and was maximal in >65 y.o. (75%). Education level increase led to decrease of those with UD, 69,3% among low professional education, 40,5% — with professional and 28,2% — among those with higher education (р<0,0001). Among persons with UD there was hypertension found in 71,6% of participants, ischemic heart disease — in 30,4%, diabetes 2 type — in 16,7%, cerebrovascular diseases — in 20,7%; overweight — in 19,2%, obesity — in 70,8%, hypercholesterolemia — in 66,0%, hyperglycemia — in 21,2%.
Conclusion. The have been found in our study regional specifics of UD are important to consider in development and implementation of regional prevention programs on healthy diet.
Aim. To assess the prevalence of the main cardiovascular risk factors (RF) and their concomitance in workers of highly harmful professions. Material and methods. In the study, men of dangerous professions participated, at the age 20-60 y.o.: 96 firefighters-rescuers, admitted to Russian centre of Catastrophe medicine (“Defense”, Moscow); 97 firefighters-rescuers at the central airmobile detachment “Centrospas” (Zhukovsky, Moscow region), 151 commando units of interior military forces of the Ministry of Internal affairs (Central regions of RF).
Results. High prevalence of risk factors of CVD revealed: overweight and obesity — 40,7%, smoking — 47%. The relation found for lean glucose and cholesterol levels. Smokers have 37% decrease of serum iron comparing to non-smokers. Smoking also does impact transaminase level: AST increase by 31%, ALT by 46%, alkaline phosphatase by 19%, LDH by 19%. Smokers have alpha-amylase increase by 16% comparing to non-smokers. Also smokers have increased urea by 8% and creatinine by 15%. Non-smokers of any age have these parameters in normal range. Smokers have age-related changes more prominent, and in any age glucose and cholesterol levels are higher than in non-smokers. Conclusion. Smoking increases CVD risk from the point of view of the main biochemical markers of blood. These changes can be treated as an inset of protein metabolism disorders related to smoking.
Aim. To do comparative research on the structure, level and dynamics of morbidity by presentation rate and mortality from cardiovascular causes (CVD) of Chelyabinskaya Region inhabitants during ten years period — 2005-2014yy.
Material and methods. The area of the study was Chelyabinskaya region — one of the economically largest regions in Russia. Data sources were official data of Federal Statistics service of RF, reports and accountability sheets from medical institutions during 2005- 2014yy.
Results. In mortality from CVD structure from CVD the leading causes are ischemic heart disease (IHD) and cerebrovascular diseases (CeVD). During the period of study there was found a growth of general and primary morbidity by admittance for CVD. In the structure of general morbidity by admittance for CVD during last 10 years IHD is the leading, in the structure of general morbidity by admittance — CeVD. For the period studied, there was decrease of mortality from CVD by 22,7%, incl. 6,3% for IHD, and 1,7 times for CeVD.
Conclusion. Regardless positive tendencies of last years, Chelyabinskaya region continues to be the region with high level of mortality from CVD. The revealed patterns of dynamics and structure of morbidity and mortality from CVD dictate the necessity of elaboration of the interventions for improvement of medical care for the patients with cardiovascular diseases at the level of regions.
Aim. To study prevalence of risk factors (RF) of cardiovascular diseases (CVD) in Tyumen region.
Material and methods. The materials was a selection of Tyumen region inhabitants of the age 25-64 y.o., assessed under multi-center, observational study ESSE-RF (Epidemiology of cardiovascular diseases and risk factors in regions of Russian Federation). Total number of participants was 1658, of those men — 30,3% (n=503), mean age 48,9±11,4 y. The prevalence assessed of such risk factors as arterial hypertension (AH), smoking, obesity, dyslipidemia, hypodynamia, excessive salt consumption (ESC), low intake of vegetables and fruits (LIVF), carbohydrate metabolism disorders (CMD).
Results. In Tyumen region the prevalence of risk factors was: AH — 49,0%, hypercholesterolemia — 56,1%, smoking — 26,8%, obesity — 40,3%, hypodynamia — 35,3%, ESC — 46,8%, LIVF — 34,1%, CMD — 5,9%. Gender differences analysis showed that in female subpopulation there are more common dyslipidemia and obesity. Males more commonly smoke and are hypodynamic. Comparing to the general ESSE-RF population, in Tyumen region there is higher prevalence of such RF as AH — 49,0% vs 44,0% and obesity — 40,3% vs 29,7%. However statistics of LIVF appears better — 34,1% vs 41,9% in general population. Conclusion. The ESSE-RF study in Tyumen region showed the specifics of epidemiology of such RF as AH, obesity, dyslipidemia, ESC, LIVF, hypodynamia, CMD. As a result, there was very high prevalence of AH revealed and unacceptably high prevalence of obesity among tyumenians, especially women, comorbid with hypercholesterolemia. This data shall be a direction for prevention management against these serious risk factors.
РАЗНОЕ
Aim. To find out, whether there is specifics of subfractional distribution of plasma lipoproteides in men and women depending on coronary atherosclerosis.
Material and methods. Totally 310 patients included (203 males, 107 females), underwent coronary arteriography; lesion of artery was assessed with Gensini Score (GS). Subfractional spectrum of plasma lipoproteides was studied via electrophoresis in 3% polyacrylamid gel with Lipoprint system (Quantimetrix Lipoprint System, USA).
Results. In the group without lesion (GS =0) gender differences of lipids, apolipoproteides and glucose utilization parameters were absent. Among coronary atherosclerosis patients (GS >0) males had lower concentrations of low and high density cholesterol (LDL, HDL), as Apo A1 and Apo B. Males with GS =0, as with GS >0 differed from females by lower lipoproteides of intermediate density (LID) — LID B and LID A, and higher part of LDL 2 and small dense particles LDL 3, but mean size of LDL particles was smaller. There were no differences in HDL subfractions distribution among men and women, but in men only if coronary atherosclerosis, there were lower cholesterol concentrations found in all HDL subfractions.
Conclusion. Gender differences are revealed in subfractional spectrum of LID and LDL: in men regardless coronary atherosclerosis with the same and even lower level of LDL cholesterol there was accumulation of more atherogenic small dense LDL particles. Gender differences in the part of HDL subfractions were not found, but in men concentration of cholesterol in each of subfractions, with coronary lesion, was lower than in women.
OPINION ON A PROBLEM
The article is focused on clinical trials of the “obesity paradox” in patients with coronary heart disease.
Regardless current achievements of medicine, chronic heart failure (CHF) is still the leading cause of cardiovascular morbidity and mortality. A special cohort in CHF mortality are patients with progressive body mass loss. Recently the assessment of cachexia is restricted only with the tests revealing present atrophy, but not to predict it. Therefore, of the most significant investigation directions is search for reliable biomarkers of early diagnostics and efficacy assessment. The article focuses on the main biomarkers having potential prediction value and recommended for cardiac cachexia assessment.
An assessment provided, of hemodynamical and biochemical parameters, vascular ageing and 5-year vascular risk at the background of combination pharmacotherapy in stable angina patients of I-III functional classes, arterial hypertension of 1-2 grade, chronic heart failure of I-II functional classes. During the study there was a positive significant dynamics found of the values of blood pressure and heart rate, vascular age and 5-year vascular risk in combination pharmacotherapy of comorbid cardiovascular pathology.
ОБЗОР
Cardiopsychiatry is relatively new field in medicine that studies psychic disorders (PD) having common pathological pathways with cardiovascular pathology (CVP). Most of them are related to stress and present with disordered neuronal activity. A working classification is proposed for PD in cardiopsychiatry. PD might be caused by: threat from actual CVP (type 1), other threatening situation (type 2a — in persons without CVP, type 2b — if CVP), “causal” non-threatening situation or even not known factors (type 3a — if without CVP, type 3b — with CVP). Literature data suggest that 2a PD does increase (though temporarily) the risk of CVP. Also the 2b PD enforces progression of CVP (possible only in specific pathogenetic variant of disease). Studies of other PD types are demanded. The review includes tables that make visible the relations of multiple terms used for PD. Information on rational selection of psychotropic drugs is provided.
ISSN 2619-0125 (Online)